Artemisinin-based combination therapy (ACT) versus atovaquoneproguanil: Do not choose between but, rather, combine them

Eli Schwartz^*, Tamar Lachish

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Access to Document

@article{c2dd46989bba4513a6bee75b285f5e7b,

title = "Artemisinin-based combination therapy (ACT) versus atovaquoneproguanil: Do not choose between but, rather, combine them",

author = "Eli Schwartz and Tamar Lachish",

year = "2016",

month = apr,

doi = "10.1136/ebmed-2015-110183",

language = "אנגלית",

volume = "21",

pages = "64",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Artemisinin-based combination therapy (ACT) versus atovaquoneproguanil

T2 - Do not choose between but, rather, combine them

AU - Schwartz, Eli

AU - Lachish, Tamar

PY - 2016/4

Y1 - 2016/4

UR - http://www.scopus.com/inward/record.url?scp=84956610009&partnerID=8YFLogxK

U2 - 10.1136/ebmed-2015-110183

DO - 10.1136/ebmed-2015-110183

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 26759150

AN - SCOPUS:84956610009

SN - 2515-446X

VL - 21

SP - 64

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 2

ER -